Mr Ivan Lewis

To ask the Secretary of State for Health and Social Care, what information his Department holds on analyses of the causes of medicine shortages in the UK.

To ask the Secretary of State for Health and Social Care, what guidance has been given to the NHS on responding to freedom of information requests on contingency planning for the UK leaving the EU; and whether that guidance is published.

To ask the Secretary of State for Health and Social Care, if he will confirm that Serious Medicines Shortage Protocols will not be appropriate for epilepsy treatments and that will be included in published guidance on Serious Medicines Protocols.

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to maintain levels of funding for epilepsy (a) research and (b) treatment after the UK leaves the EU.

To ask the Secretary of State for Work and Pensions, how many people with epilepsy have been helped into employment through (a) the Work and Health Programme, (b) Personal Support Package and (c) Access to Work.

To ask the Secretary of State for Work and Pensions, what steps she is taking to encourage SMEs to sign up to the Disability Confident scheme.

To ask the Secretary of State for Work and Pensions, what steps he is taking to ensure the effectiveness of the personal independence payment assessment process for individuals with (a) fluctuating conditions, and (b) neurological conditions that don’t co...

To ask the Secretary of State for Health and Social Care, what plans he has to (a) monitor and (b) mitigate the risks to patient safety that could result from a Serious Shortage Protocol and planning for the UK leaving the EU without a deal; and if he wil...

To ask the Secretary of State for Health and Social Care, for what reason there is no national service specification for ceroid lipofuscinosis type 2 (CLN2).

To ask the Secretary of State for Health and Social Care, whether his Department has plans to review NICE’s criteria for reviewing new medicines so that it ensures appropriate access to treatments by people with rare diseases.

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to make cerliponase alfa available to eligible children in advance of an agreement being signed between NHS and the manufacturer of the drug.

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to child and adolescent mental health services for schools and families.

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) standard and (b) capacity of NHS crisis and inpatient services.

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to face-to-face talking therapies for people with mental health problems.

To ask the Secretary of State for Health and Social Care, pursuant to the Adjournment debate of 17 July 2018 on Access to Orkambi, Official Report, cols 377-386, what steps he is taking to (a) facilitate and (b) participate as appropriate in a meeting bet...

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 June 2018 to Question 148619, whether the Public Health England’s Operational Delivery Network Hepatitis C profile tool will be published before the summer recess.

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 June 2018 to Question 148619, if he will set a publication date for Public Health England’s Operational Delivery Network Hepatitis C profile tool.

To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost to the public purse of treating people with cystic fibrosis in each of the last five years.

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of NHS England taking a portfolio approach to its evaluation of the cost-effectiveness of cystic fibrosis medicines.

To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with representatives of cystic fibrosis charities on the availability of Orkambi on the NHS for people with cystic fibrosis.